Page last updated: 2024-09-05

sb 203580 and Friedreich Disease

sb 203580 has been researched along with Friedreich Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cotticelli, MG; Kaur, A; Lin, D; Ruff, E; Tobias, JW; Wang, Y; Wilson, RB; Xia, S1

Other Studies

1 other study(ies) available for sb 203580 and Friedreich Disease

ArticleYear
Identification of p38 MAPK as a novel therapeutic target for Friedreich's ataxia.
    Scientific reports, 2018, 03-22, Volume: 8, Issue:1

    Topics: Cells, Cultured; Computational Biology; Enzyme Inhibitors; Fibroblasts; Frataxin; Friedreich Ataxia; Gene Expression Profiling; Gene Knockdown Techniques; Humans; Imidazoles; Iron-Binding Proteins; Mitogen-Activated Protein Kinase 14; Phosphorylation; Primary Cell Culture; Pyridines; RNA, Small Interfering; Signal Transduction

2018